Robert Kramer
biomedicine
Harbour BioMed
China
Biography
CSO of SalvaRx Therapeutics and Sonnet Biotherapeutics Previously, VP and Global Head Oncology Discovery, Johnson & Johnson VP Oncology and Immunology Drug Discovery & Princeton Research Site Head, Bristol-Myers Squibb Led and oversaw Oncology and Immunology programs that received FDA approvals for treating patients with chronic myeloid leukemia, breast cancer and melanoma Director, Oncology and Immunology Research, Lederle-Wyeth Assistant Professor at Harvard Medical School Staff Fellow NIH PhD in Pharmacology from the University of Vermont
Research Interest
Pharmacology
